EX-1.1
from 8-K
48 pages
Watson Pharmaceuticals, Inc. $3,900,000,000 $1,200,000,000 1.875% Notes Due 2017 $1,700,000,000 3.250% Notes Due 2022 $1,000,000,000 4.625% Notes Due 2042 Underwriting Agreement September 27, 2012 Merrill Lynch, Pierce, Fenner & Smith Incorporated Wells Fargo Securities, LLC Barclays Capital Inc. and J.P. Morgan Securities LLC Underwriting Agreement
12/34/56
EX-1.1
from 8-K
38 pages
Watson Pharmaceuticals, Inc. $850,000,000 $450,000,000 5.000% Notes Due 2014 $400,000,000 6.125% Notes Due 2019 Underwriting Agreement August 18, 2009 Banc of America Securities LLC and Barclays Capital Inc. Underwriting Agreement
12/34/56
